Massively Parallel Sequencing Uncovered Disease-associated Variant Spectra of Glucose-6-phosphate Dehydrogenase Deficiency, Phenylketonuria and Galactosemia in Vietnamese Pregnant Women

Background: Several inherited metabolic diseases are underreported in Vietnam, namely glucose-6-phosphate dehydrogenase deficiency (G6PDd), phenylketonuria (PKU) and galactosemia (GAL). Whilst massively parallel sequencing (MPS) allows researchers to screen several loci simultaneously for pathogenic variants, no screening programme uses MPS to uncover the variant spectra of these diseases in the Vietnamese population.

Methods: Pregnant women (mean age of 32) from across Vietnam attending routine prenatal health checks agreed to participate and had their blood drawn. MPS was used to detect variants in their G6PD, PAH and GALT genes.

Results: Of 3259 women screened across Vietnam, 450 (13.8%) carried disease-associated variants for G6PD, PAH and GALT. The prevalence of carriers was 8.9% (291 of 3259) in G6PD and 4.6% (152 of 3259) in PKU, whilst GAL was low at 0.2% (7 of 3259). Two GALT variants, c.593 T > C and c.1034C > A, have rarely been reported.

Conclusion: This study highlights the need for routine carrier screening, where women give blood whilst receiving routine prenatal care, in Vietnam. The use of MPS is suitable for screening multiple variants, allowing for identifying rare pathogenic variants. The data from our study will inform policymakers in constructing cost-effective genetic metabolic carrier screening programmes.

Citing Articles

Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions.

Ansari M, Chauhan W, Shoaib S, Alyahya S, Ali M, Ashraf H Int J Obes (Lond). 2023; 47(12):1179-1199.

PMID: 37696926 DOI: 10.1038/s41366-023-01369-3.

Massively parallel sequencing uncovered disease-associated variant spectra of glucose-6-phosphate dehydrogenase deficiency, phenylketonuria and galactosemia in Vietnamese pregnant women.

Nguyen T, Le Q, Hoang D, Nguyen H, Thi Ha T, Nguyen M Mol Genet Genomic Med. 2022; 10(7):e1959.

PMID: 35502621 PMC: 9266602. DOI: 10.1002/mgg3.1959.

References

Wada Y, Kikuchi A, Arai-Ichinoi N, Sakamoto O, Takezawa Y, Iwasawa S . Biallelic GALM pathogenic variants cause a novel type of galactosemia. Genet Med. 2018; 21(6):1286-1294. DOI: 10.1038/s41436-018-0340-x. View

Hugh-Jones K, NEWCOMB A, HSIA D . The genetic mechanism of galactosaemia. Arch Dis Child. 1960; 35:521-8. PMC: 2012648. DOI: 10.1136/adc.35.184.521. View

Ong K, Iwagami M, Araki H, Khattignavong P, Soundala P, Keomalaphet S . Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030. Malar J. 2019; 18(1):75. PMC: 6416863. DOI: 10.1186/s12936-019-2715-0. View

Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielski E . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2000; 29(1):308-11. PMC: 29783. DOI: 10.1093/nar/29.1.308. View

Bancone G, Menard D, Khim N, Kim S, Canier L, Nguong C . Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion. Malar J. 2019; 18(1):20. PMC: 6343352. DOI: 10.1186/s12936-019-2652-y. View

Nuchprayoon I, Sanpavat S, Nuchprayoon S . Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population. Hum Mutat. 2002; 19(2):185. DOI: 10.1002/humu.9010. View

Howes R, Piel F, Patil A, Nyangiri O, Gething P, Dewi M . G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012; 9(11):e1001339. PMC: 3496665. DOI: 10.1371/journal.pmed.1001339. View

Ong K, Kosugi H, Thoeun S, Araki H, Thandar M, Iwagami M . Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond. BMJ Glob Health. 2017; 2(3):e000415. PMC: 5656182. DOI: 10.1136/bmjgh-2017-000415. View

Lazarin G, Haque I, Nazareth S, Iori K, Scott Patterson A, Jacobson J . An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genet Med. 2012; 15(3):178-86. PMC: 3908551. DOI: 10.1038/gim.2012.114. View

10.

Ruiz M, Jover S, Armas M, Duque M, Santana C, Giros M . Galactosaemia presenting as congenital pseudoafibrinogenaemia. J Inherit Metab Dis. 1999; 22(8):943-4. DOI: 10.1023/a:1005660011709. View

11.

He Y, Zhang Y, Chen X, Wang Q, Ling L, Xu Y . Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype-phenotype association throughout an activity distribution. Sci Rep. 2020; 10(1):17106. PMC: 7555859. DOI: 10.1038/s41598-020-74200-y. View

12.

Blau N, Shen N, Carducci C . Molecular genetics and diagnosis of phenylketonuria: state of the art. Expert Rev Mol Diagn. 2014; 14(6):655-71. DOI: 10.1586/14737159.2014.923760. View

13.

Matsuoka H, Wang J, Hirai M, Arai M, Yoshida S, Kobayashi T . Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G>A) is the most common variant in the Myanmar population. J Hum Genet. 2004; 49(10):544-547. DOI: 10.1007/s10038-004-0187-7. View

14.

Williams R, Mamotte C, Burnett J . Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev. 2008; 29(1):31-41. PMC: 2423317. View

15.

Ganjekarimi A, Senemar S, Tarami B, Bazrgar M . The prevalence and clinical study of galactosemia disease in a pilot screening program of neonates, southern iran. Iran J Public Health. 2012; 40(4):99-104. PMC: 3481732. View

16.

Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, Yamnuan R . Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand. Malar J. 2011; 10:368. PMC: 3286437. DOI: 10.1186/1475-2875-10-368. View

17.

Hafid N, Christodoulou J . Phenylketonuria: a review of current and future treatments. Transl Pediatr. 2016; 4(4):304-17. PMC: 4728993. DOI: 10.3978/j.issn.2224-4336.2015.10.07. View

18.

Liang Y, Huang M, Cheng C, Chao H, Fwu V, Chiang S . The mutation spectrum of the phenylalanine hydroxylase (PAH) gene and associated haplotypes reveal ethnic heterogeneity in the Taiwanese population. J Hum Genet. 2014; 59(3):145-52. DOI: 10.1038/jhg.2013.136. View

19.

McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

20.

Hue N, Charlieu J, Chau T, Day N, Farrar J, Hien T . Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population. Malar J. 2009; 8:152. PMC: 2717975. DOI: 10.1186/1475-2875-8-152. View